Jiayuan Technology: granted 1975300 restricted shares to 163 incentive objects

Synthetic Biology: Who Will Emerge as the Winner?

The 21st century is the century of biology. Synthetic biology is believed to be a ‘World Changing’ industry. But the potential risks like cost control and commercialization pathways are fatefully tied to the ups and downs of countless investment decisions and the destiny of the many new start-ups getting involved. We look forward to seeing an emerging ‘giant’ on the horizon of this exciting industry.

Surgerii Robotics: Single-Port Surgical Robots Poised to Transform Surgery

The worldwide surgical robotic market is expected to grow at a booming CAGR of 5.8% during 2022 to 2030, rising from USD 5.05 billion in 2022 to USD 21.41 billion in 2030. Of which, the single-port surgical robots that result in less pain, fewer scars, and quicker recovery, have tremendous up potential.

2022 SMIC Net Income Up 13% YOY, Revenue Up 39% YOY

SMIC(Chinese:中芯国际): In terms of industry patterns, the international environment of the semiconductor industry is undergoing a new round of changes, with the global supply chain showing a trend of regionalization.

Sense Time Net Annual Revenue CNY 3.8 Bn, Building Multimodal Large Model for Future

As an early layout of large computing power and large model AI enterprise in China, Sense Time (Chinese:商汤科技) is preparing before the coming of the AIGC era and trying to seize the first opportunity.

Bloomage: Injecting Biotechnology into Beauty Care

Listed on the Chinese Star Market in November 2019, Bloomage was trading at CNY 138.01 as of June 24, 2020, over 38% higher than the IPO price of CNY 100.